Company / Cash per Share
SELLAS Life Sciences Group, Inc. Cash per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.23
FY2024
5-year range
$0.12 / $6.95
FY2020-FY2024
Trend
+88.4%
vs FY2023
Sector context
#193 of 205
Health Care
What the data says
Among 205 Health Care companies, SELLAS Life Sciences Group, Inc. is in the bottom 6% for cash per share. Cash per Share returned to growth in FY2024 after 3 years of decline, reaching $0.23.
Based on SEC 10-K filings.
0.23 in FY2024 with a 5-year CAGR of -39.7%.
Declined from $1.08 to $0.23 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -46.7%
- 5-Year CAGR
- -39.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 205This company $0.23 Sector average $72.93
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2024, cash per share increased 88.4% year-over-year.
- Ranks #193 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2018.
- Lowest cash per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.23 | +88.4% |
| FY2023 | $0.12 | -88.8% |
| FY2022 | $1.08 | -28.1% |
| FY2021 | $1.50 | -78.4% |
| FY2020 | $6.95 | +144.3% |
| FY2019 | $2.84 | -86.1% |
| FY2018 | $20.41 | +1959.4% |
| FY2017 | $0.99 | +34.5% |
| FY2016 | $0.74 | +5668.7% |
| FY2015 | $0.01 | -94.1% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026